Skip to content
← Full study record

NCT00627393 · OUTCOME

Overall Incidence of Adverse Effects

Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) · Source last updated 2015-04-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Measured through Day 42

Analysis population: All randomized subjects.

Groups in this outcome

Control Arm

Received antimicrobial therapy alone.

Granulocyte Arm

Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Control Arm58
Granulocyte Arm56

Reported measurements

0 Event
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm33Not reportedNot reportedNot reportedNot reported
Granulocyte Arm30Not reportedNot reportedNot reportedNot reported
1 Event
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm21Not reportedNot reportedNot reportedNot reported
Granulocyte Arm20Not reportedNot reportedNot reportedNot reported
2 Events
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm2Not reportedNot reportedNot reportedNot reported
Granulocyte Arm5Not reportedNot reportedNot reportedNot reported
3 Events
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm1Not reportedNot reportedNot reportedNot reported
Granulocyte Arm0Not reportedNot reportedNot reportedNot reported
6 Events
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm0Not reportedNot reportedNot reportedNot reported
Granulocyte Arm1Not reportedNot reportedNot reportedNot reported
9 Events
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm1Not reportedNot reportedNot reportedNot reported
Granulocyte Arm0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        33
      2. group Id
        OG001
        value
        30
    title
    0 Event
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        21
      2. group Id
        OG001
        value
        20
    title
    1 Event
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        2
      2. group Id
        OG001
        value
        5
    title
    2 Events
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        1
      2. group Id
        OG001
        value
        0
    title
    3 Events
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
    title
    6 Events
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        1
      2. group Id
        OG001
        value
        0
    title
    9 Events
denoms
  1. counts
    1. group Id
      OG000
      value
      58
    2. group Id
      OG001
      value
      56
    units
    Participants
groups
  1. description
    Received antimicrobial therapy alone.
    id
    OG000
    title
    Control Arm
  2. description
    Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.
    id
    OG001
    title
    Granulocyte Arm
param Type
NUMBER
population Description
All randomized subjects.
reporting Status
POSTED
time Frame
Measured through Day 42
title
Overall Incidence of Adverse Effects
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice